相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers
Fei Teng et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2022)
A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors
Olumide B. Gbolahan et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosis
G. D. Marijn Veerman et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma
Chun A. Changou et al.
ONCOLOGIST (2021)
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach
Emily J. Cox et al.
PHARMACOLOGICAL REVIEWS (2021)
Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation
Md Masud Parvez et al.
DRUG METABOLISM AND DISPOSITION (2021)
Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients
Fang Cheng et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)
Clinical relevance of St. John's wort drug interactions revisited
Simon Nicolussi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?
A. David Rodrigues et al.
DRUG METABOLISM AND DISPOSITION (2020)
Drug-drug-gene interactions and adverse drug reactions
Mustafa Adnan Malki et al.
PHARMACOGENOMICS JOURNAL (2020)
Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects
Matthew G. McDonald et al.
DRUG METABOLISM AND DISPOSITION (2020)
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
C. Louwrens Braal et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues
Sudip Kumar Mandal et al.
PHARMACOLOGICAL RESEARCH (2020)
Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content
Sigrun Chrubasik-Hausmann et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Pharmacodynamic Drug-Drug Interactions
Jin Niu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen
Koen G. A. M. Hussaarts et al.
CANCERS (2019)
The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer
Shreya Tocaciu et al.
INTEGRATIVE CANCER THERAPIES (2018)
The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
Kazuhiro Nishikawa et al.
JOURNAL OF CANCER (2018)
An evaluation of garlic products available in Australian pharmacies-From the label to the laboratory
Wai-Jo Jocelin Chan et al.
JOURNAL OF HERBAL MEDICINE (2018)
Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling
Hongyan Zhang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy
Jiang Shu-long et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2017)
Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
Jeffry Adiwidjaja et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Complementary medicine products: interpreting the evidence base
Marc Cohen et al.
INTERNAL MEDICINE JOURNAL (2017)
Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study
Jiali Li et al.
DRUG METABOLISM AND DISPOSITION (2017)
Prediction of Clinically Relevant Herb-Drug Clearance Interactions Using Sandwich-Cultured Human Hepatocytes: Schisandra spp. Case Study
Jonathan P. Jackson et al.
DRUG METABOLISM AND DISPOSITION (2017)
Mechanisms and Consequences of Drug-Drug Interactions
David J. Greenblatt
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
Chu Matsuda et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Effects of blending wheatgrass juice on enhancing phenolic compounds and antioxidant activities of traditional kombucha beverage
Tzu-Ying Sun et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2015)
A traditional Japanese medicine-Hangeshashinto (TJ-14)-alleviates chemoradiation-induced mucositis and improves rates of treatment completion
Taku Yamashita et al.
SUPPORTIVE CARE IN CANCER (2015)
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
Toru Aoyama et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
The Effect of St John's Wort on the Pharmacokinetics of Docetaxel
Andrew K. L. Goey et al.
CLINICAL PHARMACOKINETICS (2014)
Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance
Ankit Saneja et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Herb-Drug Interactions: Challenges and Opportunities for Improved Predictions
Scott J. Brantley et al.
DRUG METABOLISM AND DISPOSITION (2014)
The effect of Echinacea purpurea on the pharmacokinetics of docetaxel
Andrew K. L. Goey et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors
Patrick J. Mansky et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2
Debra L. Barton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
PharmGKB summary: tamoxifen pathway, pharmacokinetics
Daniel J. Klein et al.
PHARMACOGENETICS AND GENOMICS (2013)
Herbal medicines: old and new concepts, truths and misunderstandings
Fabio Carmona et al.
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY (2013)
Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer
Janette Vardy et al.
SPRINGERPLUS (2013)
Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cells
C. Fahrmayr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A study about drug combination therapy of Schisandra sphenanthera extract and Rapamycin in healthy subjects
Ruidong Li et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion-Transporting Polypeptides
M. J. Dolton et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Marginal increase of sunitinib exposure by grapefruit juice
Nielka P. van Erp et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
A Phase I Study of the Chinese Herbal Medicine PHY906 as a Modulator of Irinotecan-based Chemotherapy in Patients with Advanced Colorectal Cancer
Shivaani Kummar et al.
CLINICAL COLORECTAL CANCER (2011)
Effect of Citrus Juice and SLCO2B1 Genotype on the Pharmacokinetics of Montelukast
E. B. Mougey et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
Shun-ichi Kimura et al.
LEUKEMIA RESEARCH (2011)
The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans
Junko Imanaga et al.
PHARMACOGENETICS AND GENOMICS (2011)
The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia
Byeongsang Oh et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy Participants
Ophelia Q. P. Yin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
Wing Lam et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study
Neela Guha et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment
Corine Ekhart et al.
CANCER TREATMENT REVIEWS (2009)
Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects
Joerg Thomas Hartmann et al.
CURRENT DRUG METABOLISM (2009)
Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo
B. J. Gurley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers
Hua-Wen Xin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: A study of prognosis, quality of life, and preferences for decision making
Fay J. Hlubocky et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: A pilot study
Gil Bar-Sela et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2007)
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel
Frederike K. Engels et al.
ONCOLOGIST (2007)
Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel
Michael C. Cox et al.
CLINICAL CANCER RESEARCH (2006)
A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction
Mary F. Paine et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer
PJ Tobin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Clinical pharmalcokinetics of docetaxel - Recent developments
SD Baker et al.
CLINICAL PHARMACOKINETICS (2006)
Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan
NPH van Erp et al.
CLINICAL CANCER RESEARCH (2005)
Cytochrome P450 enzymes mechanism based inhibitors: Common sub-structures and reactivity
E Fontana et al.
CURRENT DRUG METABOLISM (2005)
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450IA2, 2D6, 2E1, and 3A4/5 phenotypes
BJ Gurley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Clinical pharmacokinetics of imatinib
B Peng et al.
CLINICAL PHARMACOKINETICS (2005)
Effect of St John's wort on imatinib mesylate pharmacokinetics
RF Frye et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The influence of St. John's Wort on the pharmacokinetics and protein binding of imatinib mesylate
P Smith
PHARMACOTHERAPY (2004)
Herb-drug interactions: An evidence based approach
PD Coxeter et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Impact of drug transporter studies on drug discovery and development
N Mizuno et al.
PHARMACOLOGICAL REVIEWS (2003)
Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice
ML Veronese et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Sirolimus: Its discovery, biological properties, and mechanism of action
SN Sehgal
TRANSPLANTATION PROCEEDINGS (2003)
Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer
K Mori et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality
J Barnes
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Role of P-glycoprotein in pharmacokinetics - Clinical implications
JH Lin et al.
CLINICAL PHARMACOKINETICS (2003)
Effect of grapefruit juice intake on etoposide bioavailability
S Reif et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
D Dürr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine oncology and haematology
H Kappauf et al.
SUPPORTIVE CARE IN CANCER (2000)
分享论文
